Spec. MD. Sinemis Çelik

Education and Specialization

• Pamukkale University Faculty of Medicine, Medical Doctor (MD)

• Pamukkale University Faculty of Medicine, Internal Medicine Residency

• Dr. Lütfi Kırdar Kartal Training and Research Hospital, Medical Oncology Sub-specialization

Directed Master's/Specialization Thesis

• Evaluation of Clinical, Pathological, Prognostic Characteristics, and Treatment Outcomes of Our Non-Hodgkin Lymphoma Cases.

Experience

• 2005–2011: Pamukkale University Faculty of Medicine, Department of Internal Medicine, Lecturer

• 2011: Hakkari State Hospital, Internal Medicine Specialist (Compulsory State Service - 3 Months)

• 2011–2014: Dr. Lütfi Kırdar Kartal Training and Research Hospital, Medical Oncology Clinic, Sub-specialty Fellow

• 2014–2017: Edirne Sultan I. Murat State Hospital, Medical Oncology Specialist

• 2017–Present: Okan University Hospital, Assistant Professor of Medical Oncology & Head of the Education Committee

• Istanbul Oncology Hospital, Medical Oncology Specialist

• Medical Park Istanbul Oncology Hospital, Medical Oncology Specialist

Languages

• English

Professional Memberships

• Turkish Society of Medical Oncology (TTOD)

• European Society for Medical Oncology (ESMO)

• American Society of Clinical Oncology (ASCO)

• Immuno-Oncology Society

• Turkish Medical Association (TTB)

Articles Published in International Peer-Reviewed Journals

• Tonyali O, Coskun U, Yüksel S, et al. (2016). Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab. Breast, 25:22-6.

• Dinc NS, Aydın K, Odabas H, Ercelep O, Tufan G, Seker M, Yasar N, Aydin D, Yüksel S, et al. (2016). Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer. Oncol Res Treat, 39(3):130-4.

• Ozcelik M, Korkmaz T, Odabas H, Gemici C, Ercelep O, Yüksel S, Mert AG, et al. (2016). Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients. Tumour Biol, 37(7).

• Ozcelik M, Odabas H, Ercelep O, Yüksel S, Mert AG, Aydin D, et al. (2016). The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients. Clin Transl Oncol, 18(6).

• Odabas H, Ulas A, Aydin K, Inanc M, Aksoy A, Yazilitas D, Turkeli M, Yüksel S, et al. (2015). Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology. Tumour Biol, 36(12).

• Aydin D, Bilici A, Yavuzer D, Kefeli U, Tan A, Ercelep O, Mert A, Yüksel S, et al. (2015). Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy. Clin Transl Oncol, 17(8).

• Cihan S, Kucukoner M, Ozdemir N, Dane F, Sendur MA, Yazilitas D, Urakci Z, Durnali A, Yüksel S, et al. (2014). Recurrence risk and prognostic parameters in stage I rectal cancers. Asian Pac J Cancer Prev, 15(13).

• Korkmaz T, Seber S, Kefeli U, Sari E, Canhoroz M, Oven B, Yildirim E, Yasar N, Aydin D, Balvan O, Sener N, Yüksel S, et al. (2013). Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis. Clin Transl Oncol, 15(7):535-40.

• Kefeli U, Yildirim ME, Aydin D, Madenci OC, Yasar N, Sener N, Mert AG, Yüksel S, et al. (2012). Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment. Biomarkers, 17(7):663-7.

Papers Published in International Scientific Meetings (Proceedings)

• The Relationship Between Collapsin Response Mediator Protein-1 (CRMP 1) Expression And Histopathological Parameters And Survival In Patient With Gastric Cancer. Nurgül Yaşar, Sibel Kayahan, Sinemis Yüksel, et al.

• T Helper 17 Cell Related Cytokines as a Prognostic Factor in Lung Cancer Patients. Bülent Karagöz, Caner Çam, Oğuz Bilgi, Metin Güden, Sinemis Çelik, Tayfun Hancılar.

• Neutrophil to Lymphocyte Ratio May Be a Prognostic Factor in Advanced stage Lung Cancer Patients. Bülent Karagöz, Metin Güden, Sinemis Çelik, Tayfun Hancılar.

Articles Published in National Peer-Reviewed Journals

• Molecular Biology of Prostate Cancer. Sinemis Çelik, Oğuz Bilgi. Türkiye Klinikleri J Med Oncol-Special Topics 2017;10(4):352-7.

• New Treatment Methods in Prostate Cancer Treatment. Türkiye Klinikleri J Med Oncol-Special Topics 2017;10(4):408-12.

Presentations Published in National Scientific Meetings

• EGFR Gene Mutation Frequency in Patients with Lung Adenocarcinoma. Sinemis Yüksel, Ayşe Ocak Duran, Hatice Odabaş, et al.

• Numerical Referral Change in Gastrointestinal Tumors: What Has Happened in the Last 10 Years? Mahmut Gümüş, Sinemis Yüksel, Özlem Ercelep, et al.

• Relationship between ERCC-1 Expression and Clinicopathological Factors in Gastric Cancer Patients. Nurgül Yaşar, Sibel Kayahan, Nur Dinç, et al.

• Can CRMP1 be a Prognostic Factor in Gastric Cancer? Nurgül Yaşar, Sibel Kayahan, Taner Korkmaz, et al.

• Gastric Cancer Presenting with Tonsilla Palatina Metastasis: A Case Report. Nurgül Yaşar, Nur Şener, Dinçer Aydın, et al.

• Renal Cell Carcinoma Metastasis Mimicking Gastric Tumor. Sinemis Yüksel, Aslıhan Güven Mert, Özlem Ercelep, et al.

• Trastuzumab Treatment in Metastatic and Her-2 Positive Gastric Cancer: A Case Report. Özlem Ercelep, Ramazan Yıldız, Taner Korkmaz, et al.

• A Case of Colon Cancer Presenting with Breast Metastasis. Nur Şener, Özlem Ercelep, Ramazan Yıldız, et al.

• Multicenter and Retrospective Analysis of Second-Line Treatment Efficacy in Small Cell Lung Cancer. Taner Korkmaz, Selçuk Şeber, Dinçer Aydın, et al.

• Histopathological Features and Relationship with Molecular Classification in Breast Cancer. Nur Şener, Nurgül Yaşar, Dinçer Aydın, et al.

• Factors Affecting Results in Second-Line Treatment of Non-Small Cell Lung Cancer. Nurgül Yaşar, Nur Şener, Dinçer Aydın, et al.

• Clinicopathological Evaluation of 35 Patients with Malignant Fibrous Histiocytoma. Melike Özçelik, Mesut Şeker, Taner Korkmaz, et al.

• EGFR Gene Mutation Frequency and its Relationship with Treatment Response in Non-Squamous Lung Cancers. Sinemis Yüksel, Özlem Ercelep, Melike Özçelik, et al.

• Diagnosis of Gastrointestinal Stromal Tumor from a Mass in the Prostate Gland: A Case Report. Özlem Ercelep, Ramazan Yıldız, Taner Korkmaz, et al.

• Primary Renal Carcinoid. Taner Korkmaz, Nurgül Yaşar, Sinemis Yüksel, et al.

• Estrogen and Progesterone Receptor Changes in Breast Cancer with Neoadjuvant Chemotherapy: A Single Center Experience. Dinçer Aydın, Nurgül Yaşar, Nur Şener, et al.